Blood-Borne Diseases

The FDA has approved Grifols’ new formulation of immune globulin (GamaSTAN) for hepatitis A virus and measles post-exposure prophylaxis.

Ebola is not the only infectious disease that health officials in the Democratic Republic of the Congo are struggling with.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The National Emerging Infectious Disease Laboratories at Boston University have the latest equipment, security redundancies, and airtight procedures and protocols. Yet, as they begin work on Ebola and Marburg, they cannot eliminate the risk of human error.

West Virginia’s Bureau for Public Health has requested the assistance from the CDC to contain the statewide hepatitis A outbreak.

The Democratic of the Congo Ministry of Health has authorized the use of 5 experimental Ebola treatments as more than 100 cases of Ebola are reported.

New research from Johns Hopkins reveals that 2 genes, CMPK2 and BCLG, are selectively activated in the presence of type 1 interferon.

A 2-week old Ebola outbreak in the DRC has already surpassed the previous outbreak

Small studies show good outcomes for previously uninfected recipients who receive kidneys from donors infected with hepatitis.

The combination of direct-acting antiviral agents glecaprevir/pibrentasvir (G/P), sofosbuvir, and ribavirin is now approved for new patient populations.

New cases of Ebola were confirmed in the North Kivu Province, just 1 week after the outbreak in the Equator Province ended.

Since August of 2017, there have been 1,170 cases of hepatitis A in Kentucky, resulting in 658 hospitalizations and 8 deaths.

Eradication of HCV in patients with HIV results in reduction of CD4+ and CD8+ T cell immune activation.

Millions with viral hepatitis go undiagnosed and untreated.

After 42 days without any new confirmed cases, the ninth Ebola outbreak in the Democratic Republic of the Congo is officially over.

Scientists supported by the NIAID discover a set of broadly neutralizing antibodies in the blood of Ebola survivors capable of providing substantial protection against the disease.

National Academies of Sciences, Engineering, and Medicine workshop highlights 5 key calls for action geared at health providers responsible for treating the infectious complications of patients with opioid use disorder.

The results indicate a significant link between sepsis and 15 cancers in elderly patients.

Hepatitis A outbreaks that have been crippling states across the nation since March of 2017 continue to wreak havoc in several cities.

There have been no confirmed cases of Ebola in the Democratic Republic of the Congo since June 6.

An increase in injection drug use in the United States has augmented the likelihood of acquiring HCV, particularly genotype 3.

The FDA seeks a permanent injunction against a company selling unapproved hand sanitizers that claim to be effective against infections from several pathogens.

Single-dose vaccines delivered via a new technology platform may offer full protection against Zika, Lassa fever, and Ebola.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The new guidelines include updates on HCV management and testing in pregnant women, individuals who inject drugs, men who have sex with men, and individuals who are incarcerated.

The FDA has provided marketing clearance for a device capable of detecting specific sepsis-causing bacterial pathogens directly from a whole blood specimen in about 5 hours.

A new study finds that some patients with sepsis who are discharged after initial treatment, and then seen through outpatient follow-up still have positive outcomes.

In sepsis patients undergoing CT imaging, contrast media administered intravenously does not significantly raise the risk of acute kidney infection.

In case you missed them, we've compiled the top five infectious disease articles from this past week.

Two more states have reported hepatitis A outbreaks since our last update—here’s what you should know about them.